About PeproTech
PeproTech is a company based in Somerset (United States) founded in 1988 by Yitzhak Stabinsky was acquired by Thermo Fisher Scientific in January 2022. PeproTech offers products and services including Recombinant Cytokines, PeproGMP Cytokines, and Animal-Free Cytokines. PeproTech operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
- Headquarter Somerset, United States
- Founders Yitzhak Stabinsky
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website peprotech.com
- Social LinkedIn X Facebook
- Acquired by Thermo Fisher Scientific (Jan 2022)
- Legal Name Thermo Fisher Scientific Inc.
- Investors
- Acquired byThermo Fisher Scientific
(Jan 2022)
Products & Services of PeproTech
PeproTech offers a comprehensive portfolio of products and services, including Recombinant Cytokines, PeproGMP Cytokines, and Animal-Free Cytokines.
Proteins used for cell culture and disease research applications
High-quality proteins for clinical therapy production
Proteins for contamination-free disease modeling
Investors in PeproTech
PeproTech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for PeproTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PeproTech
5 people are tracked at PeproTech (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Yitzhak Stabinsky | Co-Founder | Leadership |
Bob Goldman | president and co-founder | Leadership |
Alban Roudaut | Ingénieur Commercial | Team |
Teib Eshkeyer-Soldini | Office Manager | Team |
Rachel Clark | Diversity And Inclusion Committee Co-chair | Team |
Complete people profiles for PeproTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PeproTech
2 dated milestones of PeproTech across 34 years, from founding to its latest funding, stage changes and deals.
- Founded PeproTech is founded.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of PeproTech
PeproTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of PeproTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PeproTech
Websites that share an audience with PeproTech (peprotech.com).
Websites whose visitors overlap most with PeproTech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rndsystems.com | 100% | 349K | #159,292 | View details | |
| cellsignal.com | 94% | 488.2K | #114,694 | View details | |
| abcam.com | 90% | 602.8K | #91,958 | View details | |
| prospecbio.com | 86% | 53.2K | #651,600 | View details | |
| am-pharma.com | 85% | 4.4K | #4,613,220 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 33 similar websites and full traffic analytics for PeproTech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 33 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Peprotech
Complete news archive for PeproTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PeproTech
10 companies that operate in the same segment as PeproTech (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PeproTech
PeproTech was founded in 1988.
PeproTech is headquartered in Somerset, United States.
PeproTech was founded in 1988 and is based in Somerset, United States. Operations focus on the development and production of recombinant proteins, including growth factors, cytokines, chemokines, neurotrophins, proteases, and animal-free variants, alongside antibodies. GMP-compliant products are provided for cell, gene, and tissue therapy applications. Additional offerings encompass ELISA kits, media supplements, and animal-free cytokine ranges for the life sciences sector.
PeproTech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
PeproTech offers Recombinant Cytokines, PeproGMP Cytokines, and Animal-Free Cytokines.
PeproTech has 1 investor. Key investors include Thermo Fisher Scientific.
PeproTech operates through Thermo Fisher Scientific Inc..
Yes. PeproTech was acquired by Thermo Fisher Scientific in January 2022.